NCT01943942View on ClinicalTrials.gov

Bioequivalence Study of Montelukast 10 mg Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

May 16, 2010

Primary Completion Date

May 26, 2010

Study Completion Date

May 26, 2010

Conditions

Asthma

Interventions

DRUG

Montelukast 10 mg

Reference product

DRUG

Montelukast 10 mg

Test product

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01943942 - Bioequivalence Study of Montelukast 10 mg Tablets | Biotech Hunter | Biotech Hunter